Blood Tubing Lines for Hemodialysis AV06C-E
Nikkiso
FDA Clearance Information
The blood tubing lines for hemodialysis AV06C-E by Nikkiso received FDA clearance through the 510(k) pathway on July 28, 2023. It is classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- For use in the extracorporeal blood circuit during hemodialysis.
- To transport blood between the patient and the hemodialysis machine during treatment.
- For use with compatible hemodialysis systems and associated blood-access components.
Clinical Applications
- Connecting a patient's blood access to the hemodialysis machine.
- Returning dialyzed blood from the machine to the patient.
- Supporting circulation through the extracorporeal hemodialysis circuit.
- Use during hemodialysis treatment for patients receiving renal replacement therapy.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- Use only with compatible Nikkiso equipment, dialysis machines, connectors and blood-access components specified in the product labeling.
- The tubing must be primed and connected using institutional hemodialysis protocols to reduce air entry, contamination and clot formation.
- Inspect packaging, tubing, connectors and clamps before use; do not use if sterile packaging is damaged or the set is compromised.
- These blood tubing lines are intended for single-use extracorporeal circuits unless the labeling specifically states otherwise; follow facility policy for disposal.
- MRI safety depends on the complete setup, including any attached clamps, sensors, connectors or other components. The tubing alone should not be considered MRI safe without manufacturer-specific information.
Frequently Asked Questions
What are the clinical indications for blood tubing lines for hemodialysis?
Blood tubing lines are indicated for use in hemodialysis to facilitate blood circulation between the patient and the dialysis machine, particularly in patients with chronic kidney disease.
What outcomes have been reported in clinical studies?
Studies have reported effective prevention of coagulation and good biocompatibility, with some exploration of sensor integration for therapy customization.
What complications have been reported?
Safety data indicate potential complications such as white thrombus formation and leakage currents, especially with central dialysis catheters.